Mattox v. United States

CourtDistrict Court, E.D. Kentucky
DecidedSeptember 2, 2025
Docket7:24-cv-00074
StatusUnknown

This text of Mattox v. United States (Mattox v. United States) is published on Counsel Stack Legal Research, covering District Court, E.D. Kentucky primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mattox v. United States, (E.D. Ky. 2025).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF KENTUCKY SOUTHERN DIVISION PIKEVILLE

MARCUS ANTHONY MATTOX, ) ) Plaintiff, ) No. 7:24-CV-74-REW ) v. ) ) UNITED STATES OF AMERICA, et al., ) MEMORANDUM OPINION ) AND ORDER Defendants. )

*** *** *** ***

In December 2024, federal inmate Marcus Mattox filed a pro se complaint asserting, among other claims, that various health care providers at USP Big Sandy were deliberately indifferent to his serious medical needs in violation of the Eighth Amendment. See DE 1 (Complaint) at 1–5, 10–13. He specifically brings claims against nurse practitioner Heather Eperson, psychologist Dr. Jessica Lucius, and health care administrators Andrew Slone, Kathryn Blankenship, and Kevin Bayes. See id. at 1–3. Mattox sues these defendants pursuant to the doctrine established in Bivens v. Six Unknown Federal Narcotics Agents, 91 S. Ct. 1999 (1971). See id. at 14. Mattox also sues the United States pursuant to the Federal Tort Claims Act, 28 U.S.C. §§ 1346(b), 2671–80 (“FTCA”). See DE 1 at 1, 14.1 These defendants collectively move to dismiss the complaint or alternatively, for summary judgment. See DE 23 (Motion). Briefing is complete. See DE 31 (Response); DE 37 (Reply). The Court will grant the motion in part and deny it in part for the reasons explained below.

1 The Court previously dismissed some of Mattox’s claims and some of the defendants upon initial screening. See DE 7 (Order) at 1–2. It does not further address the dismissed claims or defendants here. I. Background Mattox’s allegations are as follows2: Between July 2023 and September 2023, Eperson informed Mattox that CT scans of his lungs revealed infection and enlarged lymph nodes. See DE 1 at 10 ¶ 1. In the months following, an outside pulmonologist ordered that Mattox receive a Breo Ellipta inhaler. See id. at ¶ 2. But Eperson did not administer Breo Ellipta to Mattox, and he began

experiencing pain. See id. at ¶ 3. According to Mattox, Assistant Health Service Administrator Blankenship did not ensure that he received Breo Ellipta and falsified medical records to cover up that failure. See id. at 11 ¶ 15. Tests conducted between November 2023 and February 2024 revealed that the infection had spread from Mattox’s right lung to his left. See id. at 10 ¶ 4. During this period, Mattox sent numerous “cop-outs”—requests to health care staff to provide medical examination and treatment—to Eperson about his condition. See id. at ¶ 5. Due to infection, he began to cough up blood, and blood was in his stool. See id. He also experienced sharp pain in his lungs and chest, loss of vision, and shortness of breath. See id. In February 2024, Eperson also failed to provide

Mattox with the protein supplement drink “Ensure” or submit him for a psychological evaluation, as directed by an outside oncologist. See id. at 11 ¶ 9. Throughout this time period, Mattox repeatedly insisted to BOP staff that he be informed of any medical test results so that he could ensure that he was transferred to a prison with a higher “Care Level” capable of providing the medical care necessary and appropriate for his conditions. See id. at 10 ¶¶ 6, 8. Despite those requests, in January 2024, Eperson did not advise him that PET scan results showed that he had liver disease. See id. at ¶¶ 6–7. Mattox only learned about the test

2 Given the procedural posture, for purposes of discussion, the Court relays as fact Mattox’s well-pleaded allegations. See D’Ambrosio v. Marino, 747 F.3d 378, 383 (6th Cir. 2014) (noting that when addressing a motion to dismiss, the Court accepts as true all well-pleaded facts in the complaint). results from his attorney during a telephone call the following month. See id. at ¶ 7. Eperson also failed to promptly inform Mattox of blood test results, which were also necessary to assure his transfer to a medical facility. See id. at 11 ¶ 9. Mattox contends that the actions or inactions of Eperson and Blankenship caused further infections and medical complications and prevented his timely transfer to a higher Care Level

prison. See id. at 11–12 ¶¶ 10–11, 16. Mattox states that he was only transferred to a higher Care Level facility after he intentionally refused medical treatment in an effort to worsen his medical conditions and after he resorted to unspecified “means other than his medical conditions.” See id. at 11 ¶¶ 10–11. In December 2023, Health Service Administrator Slone unilaterally canceled a bronchoscopy procedure ordered by an external specialist without first consulting Mattox’s physician. See id. at 11 ¶ 12. This cancellation, along with several other medical appointments Slone canceled, caused further bodily injury to Mattox. See id. at 11 ¶¶ 12–14. As a result, Mattox was also placed on “medical hold,” preventing or delaying improperly his transfer to a higher Care

Level facility. See id. at 11 ¶ 14. On February 6, 2024, Mattox experienced a suicidal episode while on the recreation yard. See id. at 12 ¶ 20. During the episode, Mattox spoke with prison psychologist Dr. Lucius for a few minutes. See id. He claims that Dr. Lucius ignored a request to speak further about his suicidal ideation, failed to perform a psychological evaluation, and failed to place him in a suicide cell. See id. Later the same day, Mattox was found unconscious in his cell; he implies a suicide attempt. See id. at ¶ 21. Dr. Lucius then placed Mattox on suicide watch for 24 hours, not the 72-hour period dictated by policy. See id. According to Mattox, Dr. Lucius’s failures to follow policy led to his suicide attempt nine days later. See id. Finally, Mattox raises allegations against Kevin Bayes, the prison’s Clinical Director. According to Mattox, Bayes did not lift the “medical hold” on him, ensure that he received proper medical attention, or assign him to a medical observation cell. See id. at ¶ 17. Bayes also falsely represented in a medical assessment sheet that Mattox was “doing well in regards to his Mental Health, taking his meds.” See id. at ¶ 18.

Mattox has filed fourteen grievances complaining of delays in receiving medical care, obtaining Ensure protein supplements, and transferring to a higher-level care facility. See DE 23- 2 (Eads Decl.) at 2 ¶ 4. In his verified complaint, Mattox claims that he also filed numerous lower- level grievances and appeals complaining about Slone’s cancellation of his medical appointments, but those documents “were either destroyed by the prison or never forwarded to the appropriate staff.” See DE 1 at 11 ¶ 13. Regardless, Mattox raised the issue of appointment cancellation in a formal grievance he filed in March 2024. See DE 23-6 (Request for Administrative Remedy) at 3. In that grievance, assigned Remedy ID # 1193156, Mattox also requested transfer to a medical facility and access to Ensure and a Breo Ellipta inhaler. See id. The warden denied the grievance,

stating that Mattox’s appointments were canceled due to his repeated refusal to attend medical appointments. See DE 23-6 at 4. The warden also noted that medical reviewers at the Central Office rejected the requested prescription for Breo Ellipta and that his current weight did not warrant Ensure. See id. Finally, the warden explained that Mattox’s diagnoses did not justify a transfer to a higher-level care facility. See id. The Mid-Atlantic Regional Office (“MARO”) and the Central Office denied Mattox’s appeals, finding that he had repeatedly interfered with his medical care by refusing to attend appointments, his conditions were stable, transfer to a medical facility was unnecessary, and no evidence indicated he was not receiving timely and appropriate medical care. See id at 6–9. This is the only grievance that Mattox has fully exhausted through the BOP’s Administrative Remedy Program (“ARP”). See DE 23-2 at 2 ¶ 4.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Davis v. Passman
442 U.S. 228 (Supreme Court, 1979)
Carlson v. Green
446 U.S. 14 (Supreme Court, 1980)
Wilson v. Seiter
501 U.S. 294 (Supreme Court, 1991)
Agostini v. Felton
521 U.S. 203 (Supreme Court, 1997)
Wilson v. Layne
526 U.S. 603 (Supreme Court, 1999)
Woodford v. Ngo
548 U.S. 81 (Supreme Court, 2006)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Jones v. Bock
549 U.S. 199 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Hill v. Lappin
630 F.3d 468 (Sixth Circuit, 2010)
Tjymas Blackmore v. Kalamazoo County
390 F.3d 890 (Sixth Circuit, 2004)
Clark-Murphy v. Foreback
439 F.3d 280 (Sixth Circuit, 2006)
Christopher Bell v. Khelleh Konteh
450 F.3d 651 (Sixth Circuit, 2006)
Kathryn Keys v. Humana, Inc.
684 F.3d 605 (Sixth Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Mattox v. United States, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mattox-v-united-states-kyed-2025.